Many of you have been here for a while. Some of us (myself included) held this stock when it was under $1 and saw it run up to nearly $8 in less than a year. Some of us made a lot of money off that run (myself NOT included) and some of us held probably too long for a decent return (me). Most of that run I believe was on the impression that Novartis was going to buy rights to the BACcel system, buy AXK outright or at the very least continue to fund the BACcel system until completion. That has not happened.
AXK has taken a nose dive and seems to be settled now most likely. This stock has a very volatile movement and can easily gain or drop 50% in a day based on volume of only 100,000 or so.
They now have a system out there which has no partner yet promises very good, automated results and are desperately in need of funding for this system.
The question is do you think this funding is coming soon? Do you believe that the BACcel system is worth a premium price for any medical device company? Or do you think this will fade away and end up just another failed endevor by the Y2K software people?
I am asking myself these questions as I try to plan my next move here. I am emotionally attached to AXK as it started out as a random bet when I first bought in 2010 and did very well for me, so I want to lean towards getting back in, but emotions should never control your stock picks.
android I think you are wrong on this one I am with this stock 4 long time now you need to study the movement of the stock that means marry the stock So you know when to get in and get out and make $$$ there is a ton of money on the sidelines for axk right now and many people know of this could get a partner or big news coming soon so my friend watch the chart and study the stock